Advertisement

Novo Nordisk Dips After Wegovy Sales Double, But Miss Analysts' Forecast

Novo Nordisk Dips After Wegovy Sales Double, But Miss Analysts' Forecast

Novo Nordisk stock dipped Thursday after sales of weight-loss drug, Wegovy, nearly doubled, but missed even more bullish expectations.